Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

241 - 250 of 5967 results found

Ceftazidime/avibactam serum concentration in patients on ECMO

Date
Thursday, March 28, 2024 - 4:00 AM
Description
CONCLUSIONS: In ECMO patients receiving ceftazidime/avibactam, ceftazidime and avibactam serum levels are above EUCAST breakpoints in most cases, justifying the use of normal dosing in ECMO patients. Increased renal clearance may lead to ceftazidime

Changes in Otitis Media During COVID-19

Date
Thursday, March 28, 2024 - 4:00 AM
Description
CONCLUSIONS: OM prevalence decreased by 45.0%, and the number of ventilating-tube insertions decreased by 28.1% in Korea during COVID-19.